Abstract
Supplementary Figure S1 shows differential sensitivity of intestinal metaplasia (IM) and normal gastric organoids to pyrvinium and pathway inhibitors, highlighting reduced ERK phosphorylation and selective growth suppression of IM organoids. Supplementary Figure S2 depicts clonal structures in IM samples using SciClone analysis and the effects of DCA-induced oxidative and DNA damage responses in gastric organoids. Supplementary Figure S3 illustrates global DNA methylation alterations in early gastric cancer, including PCA/clustering results, subtype-specific methylation patterns, and associations with replication timing and mutational signatures. Supplementary Figure S4 shows shared germline variant profiles among IM samples from six countries, with UpSet plots and pairwise SNP comparisons illustrating inter-population genomic overlap. Supplementary Figure S5 demonstrates risk stratification for early gastric neoplasia among IM patients using combined clinical and genomic predictors, including ROC and PR curve analyses. Supplementary Figure S6 presents histologic, immunohistochemical, and FISH validation of bacterial presence in gastric cancer tissues, confirming localization of Streptococcus and S. anginosus within tumor regions. Supplementary Figure S7 displays spatial mapping of bacterial reads in gastric cancer tissues, showing host cell-state organization and bacterial localization inferred from Stereopy analysis.